These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 22234752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
    Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R.
    Aliment Pharmacol Ther; 2003 Feb 15; 17(4):537-45. PubMed ID: 12622762
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G.
    Dis Esophagus; 2013 Jul 15; 26(5):443-50. PubMed ID: 22862422
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Higher prevalence of obesity in erosive gastroesophageal reflux disease].
    Biccas BN, Lemme EM, Abrahão LJ, Aguero GC, Alvariz A, Schechter RB.
    Arq Gastroenterol; 2009 Jul 15; 46(1):15-9. PubMed ID: 19466304
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
    Savarino E, Zentilin P, Mastracci L, Dulbecco P, Marabotto E, Gemignani L, Bruzzone L, de Bortoli N, Frigo AC, Fiocca R, Savarino V.
    J Gastroenterol; 2013 Apr 15; 48(4):473-82. PubMed ID: 23001252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V.
    Am J Gastroenterol; 2010 May 15; 105(5):1053-61. PubMed ID: 19997095
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CORRELATION BETWEEN SYMPTOMS AND REFLUX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE.
    Batista AO, Dantas RO.
    Arq Gastroenterol; 2022 May 15; 59(2):184-187. PubMed ID: 35830026
    [Abstract] [Full Text] [Related]

  • 15. Overweight is a risk factor for both erosive and non-erosive reflux disease.
    Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P, Savarino V.
    Dig Liver Dis; 2011 Dec 15; 43(12):940-5. PubMed ID: 21944835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.